On the clinical pharmacology of prednimustine.
作者信息
Plym Forshell G, Gunnarsson P O, Liljekvist J
出版信息
Br J Clin Pharmacol. 1983 Dec;16(6):760-1. doi: 10.1111/j.1365-2125.1983.tb02263.x.
Abstract
摘要
相似文献
1
On the clinical pharmacology of prednimustine.关于泼尼松氮芥的临床药理学
Br J Clin Pharmacol. 1983 Dec;16(6):760-1. doi: 10.1111/j.1365-2125.1983.tb02263.x.
2
The clinical pharmacology of chlorambucil and prednimustine.苯丁酸氮芥和泼尼松氮芥的临床药理学。
Br J Clin Pharmacol. 1983 Dec;16(6):762-3. doi: 10.1111/j.1365-2125.1983.tb02264.x.
3
Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).游离苯丁酸氮芥及其泼尼松龙酯（泼尼莫司汀，Leo 1031）给药后在人体内的药代动力学。
Eur J Clin Pharmacol. 1983;24(2):251-3. doi: 10.1007/BF00613827.
4
Studies on the pharmacokinetics of chlorambucil and prednimustine in man.苯丁酸氮芥和泼尼莫司汀在人体中的药代动力学研究。
Br J Clin Pharmacol. 1983 Feb;15(2):253-8. doi: 10.1111/j.1365-2125.1983.tb01494.x.
5
The pharmacokinetics of prednimustine and chlorambucil in the rat.
Cancer Chemother Pharmacol. 1981;6(1):85-91. doi: 10.1007/BF00253015.
6
Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.
Cancer Chemother Pharmacol. 1986;16(2):85-90. doi: 10.1007/BF00256154.
7
The antitumor effect of prednimustine in vitro and in vivo.泼尼莫司汀的体内外抗肿瘤作用。
Semin Oncol. 1986 Mar;13(1 Suppl 1):3-7.
8
Prednimustine: the rationale for clinical development.泼尼莫司汀：临床开发的基本原理。
Semin Oncol. 1986 Mar;13(1 Suppl 1):1-2.
9
Prednisolone plasma levels after oral administration of Prednimustine. Comparison with levels obtained after administration of an equimolar dose of prednisolone.口服泼尼松氮芥后泼尼松龙的血浆水平。与给予等摩尔剂量泼尼松龙后获得的水平进行比较。
Oncology. 1981;38(6):351-5. doi: 10.1159/000225586.
10
Comparison of the cytotoxic effect of prednimustine in cultured cells with high or low levels of metallothionein.泼尼松氮芥对金属硫蛋白水平高或低的培养细胞的细胞毒性作用比较。
Acta Pharmacol Toxicol (Copenh). 1984 Jan;54(1):49-57. doi: 10.1111/j.1600-0773.1984.tb01894.x.
引用本文的文献
1
The clinical pharmacology of chlorambucil and prednimustine.苯丁酸氮芥和泼尼松氮芥的临床药理学。
Br J Clin Pharmacol. 1983 Dec;16(6):762-3. doi: 10.1111/j.1365-2125.1983.tb02264.x.
2
Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.
Cancer Chemother Pharmacol. 1986;16(2):85-90. doi: 10.1007/BF00256154.
本文引用的文献
1
Studies on the pharmacokinetics of chlorambucil and prednimustine in man.苯丁酸氮芥和泼尼莫司汀在人体中的药代动力学研究。
Br J Clin Pharmacol. 1983 Feb;15(2):253-8. doi: 10.1111/j.1365-2125.1983.tb01494.x.
2
Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).游离苯丁酸氮芥及其泼尼松龙酯（泼尼莫司汀，Leo 1031）给药后在人体内的药代动力学。
Eur J Clin Pharmacol. 1983;24(2):251-3. doi: 10.1007/BF00613827.
3
Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.烷化皮质类固醇酯Leo 1031对淋巴增生性疾病的治疗作用。II. 淋巴细胞性淋巴瘤
Acta Med Scand. 1975 Apr;197(4):323-7. doi: 10.1111/j.0954-6820.1975.tb04926.x.
4
Therapeutic effect of Leo 1031, an alkylating corticosteroid ester, in lymphoproliferative disorders. I. chronic lymphocytic leukaemia.
Acta Med Scand. 1975 Apr;197(4):317-22. doi: 10.1111/j.0954-6820.1975.tb04925.x.
5
Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031).
Oncology. 1978;35(3):103-6. doi: 10.1159/000225266.
Zotero 插件